• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首过灌注心血管磁共振参数作为左心室舒张功能障碍的替代标志物:与心导管术的对照验证。

First-pass perfusion cardiovascular magnetic resonance parameters as surrogate markers for left ventricular diastolic dysfunction: a validation against cardiac catheterization.

机构信息

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.

Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.

出版信息

Eur Radiol. 2022 Dec;32(12):8131-8139. doi: 10.1007/s00330-022-08938-6. Epub 2022 Jul 2.

DOI:10.1007/s00330-022-08938-6
PMID:35779091
Abstract

OBJECTIVES

The non-invasive assessment of left ventricular (LV) diastolic dysfunction remains a challenge. The role of first-pass perfusion cardiac magnetic resonance (CMR) parameters in quantitative hemodynamic analyses has been reported. We therefore aimed to validate the diagnostic ability and accuracy of such parameters against cardiac catheterization for LV diastolic dysfunction in patients with left heart disease (LHD).

METHODS

We retrospectively enrolled 77 LHD patients who underwent CMR imaging and cardiac catheterization. LV diastolic dysfunction was defined as pulmonary capillary wedge pressure (PCWP) or LV end-diastolic pressure (LVEDP) > 12 mmHg on catheterization. On first-pass perfusion CMR imaging, pulmonary transit time (PTT) was measured as the time for blood to pass from the left ventricle to the right ventricle (RV) through the pulmonary vasculature. Pulmonary transit beat (PTB) was the number of cardiac cycles within the interval, and pulmonary blood volume indexed to body surface area (PBVi) was the product of PTB and RV stroke volume index (RVSVi).

RESULTS

Of the 77 LHD patients, 53 (68.83%) were found to have LV diastolic dysfunction, and showed significantly higher PTTc, PTB, and PBVi (p < 0.05) compared with those without. In multivariate analyses, only PTTc and PTB were identified as independent predictors of LV diastolic dysfunction (p < 0.05). With an optimal cutoff of 11.9 s, PTTc yielded the best diagnostic performance for LV diastolic dysfunction (area under the curve = 0.83, p < 0.001).

CONCLUSIONS

PTTc may represent a non-invasive quantitative surrogate marker for the detection and assessment of diastolic dysfunction in LHD patients.

KEY POINTS

• PTTc yielded the best diagnostic accuracy for diastolic dysfunction, with an optimal cutoff of 11.9 s, and a specificity of 100%. • PTTc and PTB were found to be independent predictors of LV diastolic dysfunction across different multivariate models with high reproducibility. • PTTc is a promising non-invasive surrogate marker for the detection and assessment of diastolic dysfunction in LHD patients.

摘要

目的

左心室(LV)舒张功能的无创评估仍然具有挑战性。已有报道称,首过灌注心脏磁共振(CMR)参数在定量血液动力学分析中的作用。因此,我们旨在验证这些参数对左心疾病(LHD)患者 LV 舒张功能障碍的诊断能力和准确性,并与心导管术进行比较。

方法

我们回顾性纳入了 77 例接受 CMR 成像和心导管术的 LHD 患者。LV 舒张功能障碍定义为心导管术时肺毛细血管楔压(PCWP)或 LV 舒张末期压(LVEDP)>12mmHg。在首过灌注 CMR 成像中,肺动脉通过时间(PTT)被定义为血液从左心室通过肺血管系统流向右心室(RV)的时间。肺动脉通过搏动(PTB)是在该时间段内的心脏搏动次数,而体表面积校正的肺血容量(PBVi)是 PTB 和 RV 每搏输出量指数(RVSVi)的乘积。

结果

77 例 LHD 患者中,53 例(68.83%)被发现存在 LV 舒张功能障碍,与无 LV 舒张功能障碍的患者相比,PTTc、PTB 和 PBVi 显著升高(p<0.05)。多变量分析显示,仅 PTTc 和 PTB 是 LV 舒张功能障碍的独立预测因子(p<0.05)。当 PTTc 的最佳截断值为 11.9s 时,对 LV 舒张功能障碍的诊断性能最佳(曲线下面积=0.83,p<0.001)。

结论

PTTc 可能是一种用于检测和评估 LHD 患者舒张功能障碍的无创定量替代指标。

重点

  1. PTTc 对舒张功能障碍的诊断准确性最佳,最佳截断值为 11.9s,特异性为 100%。

  2. PTTc 和 PTB 是不同多变量模型中 LV 舒张功能障碍的独立预测因子,具有较高的可重复性。

  3. PTTc 是一种有前途的无创替代标志物,可用于检测和评估 LHD 患者的舒张功能障碍。

相似文献

1
First-pass perfusion cardiovascular magnetic resonance parameters as surrogate markers for left ventricular diastolic dysfunction: a validation against cardiac catheterization.首过灌注心血管磁共振参数作为左心室舒张功能障碍的替代标志物:与心导管术的对照验证。
Eur Radiol. 2022 Dec;32(12):8131-8139. doi: 10.1007/s00330-022-08938-6. Epub 2022 Jul 2.
2
Association of Pulmonary Transit Time and Pulmonary Blood Volume From First-Pass Perfusion Cardiac MRI With Diastolic Dysfunction and Left Ventricle Deformation in Restrictive Cardiomyopathy.首过法心脏 MRI 中肺通过时间和肺血容量与限制性心肌病舒张功能障碍和左心室变形的关系。
J Magn Reson Imaging. 2024 Dec;60(6):2343-2355. doi: 10.1002/jmri.29283. Epub 2024 Feb 14.
3
Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy.肺血容量指数作为肥厚型心肌病血液动力学充血的定量生物标志物。
Eur Heart J Cardiovasc Imaging. 2019 Dec 1;20(12):1368-1376. doi: 10.1093/ehjci/jez213.
4
Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR.利用心肌灌注 CMR 评估肺通过时间和肺血容量的预后价值。
JACC Cardiovasc Imaging. 2021 Nov;14(11):2107-2119. doi: 10.1016/j.jcmg.2021.03.029. Epub 2021 May 19.
5
Noninvasive Prediction of Pulmonary Capillary Wedge Pressure in Patients With Normal Left Ventricular Ejection Fraction: Comparison of Cardiac Magnetic Resonance With Comprehensive Echocardiography.无创性预测左心室射血分数正常患者的肺毛细血管楔压:心脏磁共振与综合超声心动图的比较。
J Am Soc Echocardiogr. 2024 May;37(5):486-494. doi: 10.1016/j.echo.2024.02.001. Epub 2024 Feb 12.
6
Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation - initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization.自由呼吸三维心脏定量磁化率映射用于区分心脏腔室内血氧-在包括与有创导管检查直接比较在内的心血管疾病患者中的初步验证。
J Cardiovasc Magn Reson. 2019 Nov 18;21(1):70. doi: 10.1186/s12968-019-0579-7.
7
Stress pulmonary circulation parameters assessed by a cardiovascular magnetic resonance in patients after a heart transplant.心脏移植后患者的心血管磁共振评估的应激肺循环参数。
Sci Rep. 2022 Apr 12;12(1):6130. doi: 10.1038/s41598-022-09739-z.
8
Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.心脏磁共振肺通过时间对射血分数降低的晚期心力衰竭患者死亡率和心力衰竭住院的预后价值。
Circ Cardiovasc Imaging. 2021 Jan;14(1):e011680. doi: 10.1161/CIRCIMAGING.120.011680. Epub 2021 Jan 13.
9
Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.应用心脏磁共振评估射血分数保留的心力衰竭患者的左心室舒张末期压力升高。
Eur Radiol. 2019 May;29(5):2360-2368. doi: 10.1007/s00330-018-5955-4. Epub 2019 Jan 10.
10
Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.应用 CMR 成像无创估计肺动脉压、流量和阻力:来自 ASPIRE 注册研究的推导和前瞻性验证。
JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047. doi: 10.1016/j.jcmg.2013.01.013. Epub 2013 Jun 13.

引用本文的文献

1
Prognostic value of novel cardiovascular magnetic resonance transit times beyond the pulmonary circulation in patients with ventricular dysfunction.心室功能障碍患者中,超出肺循环的新型心血管磁共振转运时间的预后价值。
Eur Radiol. 2025 Apr;35(4):2180-2188. doi: 10.1007/s00330-024-11045-3. Epub 2024 Aug 30.
2
[Using CT to Evaluate Cardiac Function].[使用CT评估心脏功能]
J Korean Soc Radiol. 2024 Mar;85(2):308-326. doi: 10.3348/jksr.2023.0140. Epub 2024 Mar 27.
3
Distribution of normalized pulmonary transit time per pathology in a population of routine CMR examinations.

本文引用的文献

1
Old wine in a new bottle: non-invasive quantitative evaluation of pulmonary congestion with pulmonary blood volume index by cardiac magnetic resonance.旧瓶装新酒:利用心脏磁共振成像通过肺血容量指数对肺充血进行无创定量评估
Eur Heart J Cardiovasc Imaging. 2019 Dec 1;20(12):1377-1378. doi: 10.1093/ehjci/jez239.
2
Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy.肺血容量指数作为肥厚型心肌病血液动力学充血的定量生物标志物。
Eur Heart J Cardiovasc Imaging. 2019 Dec 1;20(12):1368-1376. doi: 10.1093/ehjci/jez213.
3
Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods.
在常规 CMR 检查的人群中,按病理分布的归一化肺通过时间。
Int J Cardiovasc Imaging. 2024 Jan;40(1):149-156. doi: 10.1007/s10554-023-02976-x. Epub 2023 Oct 26.
4
Association between systemic sclerosis and left ventricle dysfunction: Findings from observational studies.系统性硬化症与左心室功能障碍之间的关联:观察性研究结果
Heliyon. 2023 Feb 28;9(3):e14110. doi: 10.1016/j.heliyon.2023.e14110. eCollection 2023 Mar.
舒张功能障碍和射血分数保留的心力衰竭:应用无创方法理解机制。
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):245-257. doi: 10.1016/j.jcmg.2018.12.034. Epub 2019 Jun 12.
4
Left Ventricular Diastolic Function: Understanding Pathophysiology, Diagnosis, and Prognosis With Echocardiography.左心室舒张功能:超声心动图理解病理生理学、诊断和预后。
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):228-244. doi: 10.1016/j.jcmg.2018.10.038. Epub 2019 Apr 12.
5
Cardiac Magnetic Resonance Evaluation of Pulmonary Transit Time and Blood Volume in Adult Congenital Heart disease.心脏磁共振评估成人先天性心脏病肺动脉通过时间和血容量。
J Magn Reson Imaging. 2019 Sep;50(3):779-786. doi: 10.1002/jmri.26684. Epub 2019 Mar 5.
6
Myocardial Strain in the Assessment of Patients With Heart Failure: A Review.心肌应变在心力衰竭患者评估中的应用:综述。
JAMA Cardiol. 2019 Mar 1;4(3):287-294. doi: 10.1001/jamacardio.2019.0052.
7
Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis.心脏电影磁共振图像上的左心室心肌变形:与轻链淀粉样变性疾病严重程度和预后的关系。
Radiology. 2018 Jul;288(1):73-80. doi: 10.1148/radiol.2018172435. Epub 2018 Apr 17.
8
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.首过对比增强 CMR 测定的肺血容积对心力衰竭门诊患者的预后价值:PROVE-HF 研究。
Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):896-904. doi: 10.1093/ehjci/jex214.
9
Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study.超声心动图多普勒估测左心室充盈压:多中心 EACVI Euro-Filling 研究结果。
Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):961-968. doi: 10.1093/ehjci/jex067.
10
Estimating Left Ventricular Filling Pressure by Echocardiography.超声心动图估测左心室充盈压。
J Am Coll Cardiol. 2017 Apr 18;69(15):1937-1948. doi: 10.1016/j.jacc.2017.01.058.